U.S. Breath Analyzers Market Size & Trends
The U.S. breath analyzers market size was estimated at USD 1.32 billion in 2024 and is expected to grow at a CAGR of 15.64% from 2025 to 2030. Factors include increasing awareness of impaired driving, the growing adoption of breath analyzers in medical applications, technological advancements, and increasing alcohol consumption. The growing demand for breath analyzers from law enforcement agencies and other institutions, such as schools, sports, and offices, to minimize alcohol abuse is a major market driver.
Download Free Sample Ask for Discount Request Customization
Breath analyzers are quick and user-friendly and offer a correct method of determining blood alcohol concentration. The factor boosting sales of these devices is the growing, stringent regulations nationwide for alcohol breath testing while driving. In addition to detecting alcohol, people also use breath analyzers to diagnose tuberculosis, asthma, and various infections. Consequently, breath analyzers observe a proliferated implementation rate in medical settings and diagnostic centers.
Technological advancements in devices are one of the significant drivers. Newer models offer enhanced accuracy, quicker results, and portability, making them more appealing for law enforcement and medical use. Innovations include more compact designs, improved sensors for detecting specific biomarkers, and integration with mobile apps for data analysis. These technological improvements increased the efficiency and versatility of breath analyzers, leading to broader adoption across various industries and contributing to market expansion.
In April 2022, the U.S. Food and Drug Administration (FDA) approved the first breathalyzer test for COVID-19, created by Inspect IR Systems, LLC. This innovative test delivers results in just three minutes and identifies five volatile organic compounds (VOCs) linked to COVID-19. The pandemic increased the need for non-invasive testing options that facilitated social distancing, making breathalyzers an effective method for detecting COVID-19 and other health issues without the risk of spreading the virus.
The healthcare sector has emerged as a significant end user of breath analyzers, utilizing them for non-invasive diagnostics of various conditions, including asthma, diabetes, and gastrointestinal disorders. For instance, in June 2024, the National Institute of Standards and Technology (NIST) announced a partnership with the Bill & Melinda Gates Foundation to develop breathalyzers for malaria and tuberculosis diagnosis, aiming to establish precise testing standards and instruments for affordable and dependable breath-based diagnostics. This expanding application in healthcare is expected to drive demand for breath analyzers, particularly in regions with limited access to traditional diagnostic tools.
Personalized healthcare is growing, focusing more on customizing medical treatments and monitoring according to individual health data. Breath analyzers play a key role in this shift by offering a non-invasive way to track biomarkers associated with various conditions. For instance, wearable breath analyzers are utilized for personalized health monitoring, giving researchers invaluable information about asthma, diabetes, and metabolic disorders. This increasing demand for tailored health management drives innovation and adoption in the market, benefiting consumer wellness and healthcare monitoring sectors.
Market Concentration & Characteristics
The U.S. market is marked by high innovation, driven by advancements in sensor technologies, miniaturization, and the development of non-invasive medical diagnostics. For instance, in November 2024, Avalon GloboCare introduced the "BrAce for Impact" affiliate marketing program to promote the KetoAir Breathalyzer device. These innovations enhance accuracy, reliability, and ease of use, contributing to market growth.
M&A activities are moderate, as companies aim to enhance their technological capabilities and increase their market share. Companies acquire smaller players to enhance their technological capabilities and expand their product portfolios. These activities allow firms to access new markets, improve R&D, and gain a competitive edge. M&A is not too frequent, and it plays a significant role in facilitating growth and innovation in the market.
Regulatory frameworks significantly impact diagnostic device safety, effectiveness, and quality, particularly in medicine. Agencies such as the U.S. FDA and the EU Medical Device Regulation (MDR) enforce strict standards that manufacturers must adhere to. Before entering the market, companies must pass extensive testing and certification processes to ensure their products meet the required regulatory criteria. This process protects patient safety and ensures that devices deliver reliable, consistent results. As regulations evolve, companies remain agile, adapting to new requirements that promote innovation while maintaining compliance and minimizing risks associated with non-compliant products.
Regional expansion is a key growth driver in the U.S. market, with stricter DUI laws in states such as California and New York. Companies expand their reach to these high-regulation areas to meet the increased demand for alcohol detection devices. Hospitals nationwide are adopting breath analyzers due to rising healthcare awareness, paving the way for wider regional adoption, particularly in metropolitan regions.
Download Free Sample Ask for Discount Request Customization
Report Coverage & Deliverables
The PDF report & online dashboard will help you understand
- Competitive benchmarking
- Historical data & forecasts
- Company revenue shares
- Regional opportunities
- Latest trends & dynamics
Technology Insights
The fuel cell technology segment held the largest revenue share of 33.89% in 2024. The high accuracy, stability, and sensitivity of this technology in detecting specific biomarkers, such as ethanol and acetone in breath, drive its growth. This technology offers rapid results and is widely used in alcohol detection, medical diagnostics, and wellness monitoring. Fuel cell-based breath analyzers are preferred for their durability and low maintenance requirements. The technology’s effectiveness in non-invasive testing continues to drive its market.
Infrared (IR) spectroscopy is anticipated to witness the fastest CAGR of 16.24% over the forecast period. Its precision in detecting specific gases and compounds in exhaled breath contributes to its growth. IR spectroscopy is non-invasive, quick, and provides real-time results, making it highly suitable for diagnosing respiratory diseases and diabetes and monitoring overall health. The technology’s growth is driven by advancements in sensor accuracy, improved portability, and the increasing demand for rapid, on-site diagnostics. Its ability to identify multiple biomarkers while offering minimal maintenance makes it a preferred choice for clinical and personal health monitoring applications.
Application Insights
The alcohol detection segment dominated the U.S. market due to increasing efforts in law enforcement to deny drunk driving and enhance public safety. High-profile incidents, stricter regulations, and increased impaired driving arrests increased demand for breath analyzers. Police officers widely use these devices during roadside checks, workplace testing, and personal use. Technological advancements, including accurate and portable devices, contribute to the segment's growth. The increasing prevalence of alcohol-related accidents and legal mandates for alcohol testing in various sectors drive the demand for reliable, quick alcohol detection solutions.
The medical applications segment is the fastest-growing U.S. market due to the rising demand for noninvasive diagnostic tools. These analyzers detect diseases such as diabetes, lung cancer, and infections, offering quick, accurate, and painless results. Growing awareness of preventive healthcare and the need for routine monitoring of conditions such as diabetes drive adoption. Instances of breath analyzers being integrated into healthcare settings, hospitals, and clinics reflect their ability to dramatically improve patient care and disease management.
End Use Insights
The law enforcement agencies segment held the largest revenue share in the market, driven by stringent regulations against driving under the influence (DUI). Factors such as increased screening and testing and the need for accurate and reliable devices drive demand. Companies such as Lifeloc Technologies provide trusted handheld evidential breath testing instruments, supporting the segment's growth by offering high-accuracy solutions for effectively enforcing DUI laws.
During the forecast period, we expect the other segment to exhibit lucrative growth in the breath analyzer market. High crime rates in specific parts and strict drug testing regulations implemented by governments in the nation are factors expected to support segment growth. Lifeloc Technologies, Inc. is among the American manufacturers of handheld evidential breath testing instruments for screening and confirmation testing of workforces in both nonregulated and DOT-regulated industries. School resource officers and administrators in middle schools, high schools, and colleges nationwide trust the firm's professional breath alcohol testers.
Download Free Sample Ask for Discount Request Customization
Key U.S. Breath Analyzer Company Insights
Companies entering with innovative products have great scope for growth, as the demand for innovative products is high. The key players are involved in new product launches, acquisitions, and partnerships to gain a competitive edge. For instance, in February 2022, FoodMarble Digestive Health Ltd. introduced the AIRE 2, a personal digestive breath tester.
Key U.S. Breath Analyzer Companies
- Drägerwerk AG & Co. KGaA
- Lifeloc Technologies, Inc.
- Quest Products, LLC.
- Intoximeters
- Alcohol Countermeasure Systems Corp.
- AK GlobalTech Corp.
- PAS Systems International, Inc
- BACtrack
- Lion Laboratories
- Advanced Safety Devices
- MPD, Inc.
- Abbott Rapid Diagnostics (formerly known as Alere)
- AlcoPro
- GenWorks Health Pvt. Ltd.
Recent Developments
-
In January 2025, Relias acquired Feedtrail to improve its workforce solutions by integrating patient feedback capabilities.
“Feedtrail is incredibly excited to join Relias and extend the impact of our patient experience solutions to the entire continuum of care. Relias’ expertise and offerings in post-acute, behavioral, and community health sectors accelerate our ability to also serve those markets and, together, to improve healthcare quality and outcomes.”
- Stephanie Alexander, Chair and CEO at Feedtrail.
-
In May 2023, GenWorks Health Pvt. Ltd. introduced FenomPro, a portable breath analyzer designed to measure Fractional exhaled Nitric Oxide (FeNO) levels, enabling more accurate detection and management of asthma. FenomPro streamlines the process of asthma diagnosis, screening, and ongoing monitoring, offering a reliable and user-friendly solution for clinical settings. Its compact design and rechargeable battery enhance portability, making it ideal for point-of-care use. The device features an intuitive interface and delivers precise test results in just 28 seconds, allowing healthcare professionals to make informed decisions quickly. By accurately measuring FeNO levels, FenomPro aids in determining whether a patient requires inhaler therapy, supporting more personalized and timely treatment plans.
-
In November 2020, MyMD Pharmaceuticals, a clinical-stage pharmaceutical company, and Akers Biosciences entered into a merger agreement. After closing the transaction, the new company was renamed MyMD Pharmaceuticals, Inc.
-
In July 2020, Lifeloc Technologies introduced two breath alcohol testers-the LX9 and the LT7. These testers are USA DOT/NHTSA-approved breathalyzers designed for workplace and law enforcement markets, featuring enhanced capabilities that improve user-friendliness and contribute to safer roadways and communities.
U.S. Breath Analyzers Market Report Scope
|
Report Attribute |
Details |
|
Revenue Forecast in 2025 |
USD 1.52 billion |
|
Revenue Forecast in 2030 |
USD 3.13 billion |
|
Growth rate |
CAGR of 15.64% from 2025 to 2030 |
|
Actual data |
2018-2024 |
|
Forecast data |
2025-2030 |
|
Quantitative units |
Revenue in USD million/billion and CAGR from 2025 to 2030 |
|
Report Coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
|
Segments Covered |
Technology, application, end use |
|
Key companies profiled |
Drägerwerk AG & Co. KGaA; Lifeloc Technologies, Inc.; Quest Products, LLC; Intoximeters; Alcohol Countermeasure Systems Corp.; AK GlobalTech Corp.; PAS Systems International, Inc.; BACtrack; Lion Laboratories; Advanced Safety Devices; MPD, Inc.; Abbott Rapid Diagnostics (formerly known as Alere); AlcoPro; GenWorks Health Pvt. Ltd. |
|
Customization scope |
Free report customization (equivalent to up to 8 analysts’ working days) with purchase. You can add or alter the scope of the country and segment. |
|
Pricing and purchase options |
Avail yourself of customized purchase options to meet your exact research needs. Explore purchase options |
U.S. Breath Analyzers Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the subsegments from 2018 to 2030. For this study, MIR has segmented the U.S. breath analyzers market report based on technology, application, and end use
-
Technology Outlook (Revenue, USD Million, 2018-2030)
-
Fuel Cell Technology
-
Semiconductor Sensor
-
Infrared (IR) Spectroscopy
-
Others
-
-
Application Outlook (Revenue, USD Million, 2018-2030)
-
Drug Abuse Detection
-
Alcohol Detection
-
Medical Applications
-
-
End Use Outlook (Revenue, USD Million, 2018-2030)
-
Law Enforcement Agencies
-
Individuals
-
Others
-
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy